These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12412273)

  • 1. [Treatment of acute myelogenous leukemia in elderly patients].
    Wierzbowska A; Robak T
    Pol Arch Med Wewn; 2001; 105 Suppl():385-9. PubMed ID: 12412273
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of acute myelogenous leukemia].
    Ono R
    Nihon Naika Gakkai Zasshi; 1992 Jul; 81(7):1040-5. PubMed ID: 1383364
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of acute myelogenous leukaemia.
    Löwenberg B
    J Intern Med Suppl; 1997; 740():17-22. PubMed ID: 9350177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful combination therapy with infusion of allogenetic bone marrow mesenchymal stem cells and CAG regimen in hypoplastic relapsed acute myelogenous leukemia.
    Lu H; Lu SF; Shen WY; Hong M; Zhang JF; Wang LX; Yang H; Li JY
    Leuk Res; 2008 Nov; 32(11):1776-9. PubMed ID: 18501425
    [No Abstract]   [Full Text] [Related]  

  • 5. G-CSF priming in acute myelogenous leukemia.
    Murashige N; Kami M; Takaue Y
    N Engl J Med; 2003 Nov; 349(21):2071-2; author reply 2071-2. PubMed ID: 14627794
    [No Abstract]   [Full Text] [Related]  

  • 6. [New therapeutic approaches in acute myeloblastic leukemia (AML) and chronic myeloid leukemia (CML)].
    Marie JP
    Bull Cancer; 1997 Apr; 84(4):451-2. PubMed ID: 9238175
    [No Abstract]   [Full Text] [Related]  

  • 7. Granulocyte colony-stimulating factor following chemotherapy in elderly patients with newly diagnosed acute myelogenous leukemia.
    Maslak PG; Weiss MA; Berman E; Yao TJ; Tyson D; Golde DW; Scheinberg DA
    Leukemia; 1996 Jan; 10(1):32-9. PubMed ID: 8558934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant granulocyte colony-stimulating factor in acute myelogenous leukemia.
    Munck JN; Deacaudin D; Koscielny S
    N Engl J Med; 1995 Oct; 333(17):1155-6. PubMed ID: 7565966
    [No Abstract]   [Full Text] [Related]  

  • 9. Priming with granulocyte colony-stimulating factor--relation to high-dose cytarabine in acute myeloid leukemia.
    Büchner T; Berdel WE; Hiddemann W
    N Engl J Med; 2004 May; 350(21):2215-6. PubMed ID: 15152074
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of granulocyte colony-stimulating factor before, during, and after fludarabine plus cytarabine induction therapy of newly diagnosed acute myelogenous leukemia or myelodysplastic syndromes: comparison with fludarabine plus cytarabine without granulocyte colony-stimulating factor.
    Estey E; Thall P; Andreeff M; Beran M; Kantarjian H; O'Brien S; Escudier S; Robertson LE; Koller C; Kornblau S
    J Clin Oncol; 1994 Apr; 12(4):671-8. PubMed ID: 7512125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possibility of remission induction in acute myeloid leukemia by granulocyte colony-stimulating factor.
    Muroi K; Tsunoda S; Yoshida M; Sakamoto S; Miura Y
    Int J Hematol; 1993 Aug; 58(1-2):129-30. PubMed ID: 7693025
    [No Abstract]   [Full Text] [Related]  

  • 12. Prophylactic use of granulocyte colony-stimulating factor after induction chemotherapy in patients with newly diagnosed acute myeloid leukemia may increase the complete remission rate: a meta-analysis of five randomised controlled trials.
    Wang J; Zhan P; Ouyang J; Chen B; Zhou R
    Leuk Lymphoma; 2009 Mar; 50(3):457-9. PubMed ID: 19263298
    [No Abstract]   [Full Text] [Related]  

  • 13. Post-remission intensive consolidation with high-dose cytarabine-based chemotherapy and granulocyte colony-stimulatory factor in adults with acute myelogenous leukemia: a preliminary report.
    Hsu HC; Chiu CF; Tan TD; Chau WK; Tseng CS; Ho CH
    Zhonghua Yi Xue Za Zhi (Taipei); 1995 Nov; 56(5):305-11. PubMed ID: 8605644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A controlled study of recombinant human granulocyte colony-stimulating factor in elderly patients after treatment for acute myelogenous leukemia. AML Cooperative Study Group.
    Dombret H; Chastang C; Fenaux P; Reiffers J; Bordessoule D; Bouabdallah R; Mandelli F; Ferrant A; Auzanneau G; Tilly H
    N Engl J Med; 1995 Jun; 332(25):1678-83. PubMed ID: 7539109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [FLAG regimen in the treatment of refractory and relapsed acute myeloid leukemia].
    Shen ZX
    Zhonghua Xue Ye Xue Za Zhi; 2011 Jan; 32(1):1-2. PubMed ID: 21429391
    [No Abstract]   [Full Text] [Related]  

  • 16. [Characteristics of elderly patients with acute myelogenous leukemia].
    Wakita A
    Nihon Rinsho; 2009 Oct; 67(10):1997-2002. PubMed ID: 19860204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disappointments in treating acute leukemia in the elderly.
    Hamblin TJ
    N Engl J Med; 1995 Jun; 332(25):1712-3. PubMed ID: 7539110
    [No Abstract]   [Full Text] [Related]  

  • 18. High-dose cytarabine, idarubicin, and granulocyte colony-stimulating factor remission induction therapy for previously untreated de novo and secondary adult acute myeloid leukemia.
    Baer MR; Christiansen NP; Frankel SR; Brunetto VL; Mrózek K; Bloomfield CD; Herzig GP
    Semin Oncol; 1993 Dec; 20(6 Suppl 8):6-12. PubMed ID: 7507264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment for adult acute myeloid leukemia: where we stand in 1995.
    Wiernik PH
    Acta Haematol Pol; 1995; 26(3):231-7. PubMed ID: 8525767
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of acute myelogenous leukemia.
    Slater S; Rohatiner AZ; Murphy M; Amess J; Carter M; Lister TA; Johnson S; Ewings M
    J Clin Oncol; 1997 Apr; 15(4):1710-1. PubMed ID: 9193373
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.